(Q24235502)

1

0 references

Shireen Gopaul

2

0 references

Elizabeth Houghton

4

0 references

Jean V Craig

5

0 references

Kate Light

6

0 references

Barry Pizer

Cochrane Database of Systematic Reviews

7

0 references

publication date

8 September 2010

0 references

published in

0 references

cites work

Nabilone: an alternative antiemetic for cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Randomised comparison of ondansetron and metoclopramide plus dexamethasone for chemotherapy induced emesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Single-dose oral granisetron versus multidose intravenous ondansetron for moderately emetogenic cyclophosphamide-based chemotherapy in pediatric outpatients with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Randomized, double-blind, crossover, placebo-controlled trial of intravenous ondansetron for the prevention of intrathecal chemotherapy-induced vomiting in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Domperidone or metoclopramide in preventing chemotherapeutically induced nausea and vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

A prospective randomized trial of the antiemetic efficacy and cost-effectiveness of intravenous and orally disintegrating tablet of ondansetron in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Antiemetic superiority of lorazepam over oxazepam and methylprednisolone as premedicants for patients receiving cisplatin-containing chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Granisetron plus dexamethasone versus granisetron alone in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

A pilot study of ondansetron plus metopimazine vs. ondansetron monotherapy in children receiving highly emetogenic chemotherapy: a Bayesian randomized serial N-of-1 trials design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Recent developments in meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Prophylaxis of acute chemotherapy-induced nausea and vomiting in children with cancer: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Children's experiences of hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Ondansetron: a review of its use as an antiemetic in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Advancing the science of symptom management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Language bias in randomised controlled trials published in English and German.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with stem cell transplant: review and consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Audit of guidelines for effective control of chemotherapy and radiotherapy induced emesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Distressing events for children and adolescents with cancer: child, parent, and nurse perceptions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

A re-evaluation of random-effects meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Patient-reported outcomes: a desirable specialty standard for oncology or an incomplete measurement approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Acute and delayed nausea and emesis control in pediatric oncology patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Direction and impact of language bias in meta-analyses of controlled trials: empirical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Measuring physical symptoms in children and adolescents with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Dexamethasone protects against Cisplatin-induced activation of the mitochondrial apoptotic pathway in human osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Exploring concerns of children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Antiemetics in children receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Ethical issues of clinical trials in children: a European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Relation between agendas of the research community and the research consumer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Neurokinin-1 receptor antagonists for prevention of chemotherapy-related nausea and vomiting in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Symptom monitoring and dependent care during cancer treatment in children: pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Symptoms and suffering at the end of life in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

A different perspective to approaching cancer symptoms in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

A different way of being: adolescents' experiences with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

One relative risk versus two odds ratios: implications for meta-analyses involving paired and unpaired binary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

Granisetron, tropisetron, and ondansetron in the prevention of acute emesis induced by a combination of cisplatin-Adriamycin and by high-dose ifosfamide delivered in multiple-day continuous infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

A multicenter, double-blind, randomized comparison of oral ondansetron 8 mg b.i.d., 24 mg q.d., and 32 mg q.d. in the prevention of nausea and vomiting associated with highly emetogenic chemotherapy. S3AA3012 Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

Safety, tolerability, efficacy and plasma concentrations of tropisetron after administration at five dose levels to children receiving cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

An increased loading dose of ondansetron: a north european, double-blind randomised study in children, comparing 5 mg/m2 with 10 mg/m2

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

Chlorpromazine with and without lorazepam as antiemetic therapy in children receiving uniform chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

Methylprednisolone for chemotherapy-induced emesis: a double-blind randomized trial in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

A randomized comparison of intravenously administered granisetron versus chlorpromazine plus dexamethasone in the prevention of ifosfamide-induced emesis in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

A randomised dose-comparison trial of granisetron in preventing emesis in children with leukaemia receiving emetogenic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

A prospective randomized trial of the anti-emetic efficacy of ondansetron and granisetron during bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

Cost-effectiveness analysis of tropisetron vs. chlorpromazine-dexamethasone in the control of acute emesis induced by highly emetogenic chemotherapy in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

A comparison of oral ondansetron syrup or intravenous ondansetron loading dose regimens given in combination with dexamethasone for the prevention of nausea and emesis in pediatric and adolescent patients receiving moderately/highly emetogenic chemo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

Ondansetron and tropisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients. Swiss Group for Clinical Cancer Research (SAKK)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

High-dose oral metoclopramide. An effective antiemetic agent

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

A randomized trial of high dose bolus metoclopramide versus low-dose continuous infusion metoclopramide in the prevention of cisplatin-induced emesis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

Serotonin receptor antagonists in prophylaxis of acute and delayed emesis induced by moderately emetogenic, single-day chemotherapy: a randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

Chlorpromazine and dexamethasone versus high-dose metoclopramide and dexamethasone in patients receiving cancer chemotherapy, particularly cis-platinum: a prospective randomized crossover study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

Pediatric oncology nurses' management of patients' symptoms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

Multiple methods in qualitative research with children: more insight or just more?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

A randomized trial of metoclopramide and a combination of dexamethasone and lorazepam for prevention of chemotherapy-induced vomiting

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

Antiemetics in children receiving cancer chemotherapy: a double-blind prospective randomized study comparing metoclopramide with chlorpromazine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

Development and validation of the pediatric nausea assessment tool for use in children receiving antineoplastic agents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

Oral granisetron for the prevention of acute late onset nausea and vomiting in patients treated with moderately emetogenic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

Randomized double-blind comparison of single high-dose ondansetron and multiple standard-dose ondansetron in chemotherapy-naive pediatric oncology patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021

Granisetron plus or minus alprazolam for emesis prevention in chemotherapy of lymphomas: a randomized multicenter trial. Granisetron Trialists Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007786.PUB2

7 January 2021